NR4A2 and Parkinson disease: Mutations in Nurr1 have been linked to Parkinson’s disease [21–24] and Nurr1 is reduced in patients with Parkinson’s disease and correlates with the loss of tyrosine hydroxylase immunoreactivity [25–27].